Inimex Pharmaceuticals (Vancouver, BC)

CMDF Investment: $3,000,000.00
Focus: Infectious Dieases  
www.inimexpharma.com

Inimex Pharmaceuticals is focused on the discovery; development and commercialization of new medicines based on a novel mechanism that will overcome the issues of drug resistance. Inimex medicines selectively augment host innate immunity without co-stimulation of pro-inflammatory responses linked to tissue damage and sepsis. Inimex is currently optimizing its first drug candidate as a new therapy against nosocomial pneumonia. Based on the Company's proprietary understanding of the mechanism of action of this drug; Inimex will simultaneously identify second generation compounds that will permit expansion into the community infection market.